169 related articles for article (PubMed ID: 33395750)
1. Mining database for the expression and clinical significance of STAT family in head and neck squamous cell carcinomas.
Ni H; Sun H; Zheng M; Bian T; Liu J; Li X; Zhang J; Liu Y
Transl Oncol; 2021 Jan; 14(1):100976. PubMed ID: 33395750
[TBL] [Abstract][Full Text] [Related]
2. Mining database for the therapeutic targets and prognostic biomarkers among STAT family in glioblastoma.
Li C; Zhou Y; Deng H; Ye Y; Zhao S; Liang S; Cai S; Lin J; Tang Y; Wu Y
Cancer Biomark; 2021; 30(2):179-191. PubMed ID: 33104022
[TBL] [Abstract][Full Text] [Related]
3. Identification of immune checkpoint inhibitors and biomarkers among STAT family in stomach adenocarcinoma.
Guo L; Fang T; Jiang Y; Liu D
Am J Transl Res; 2020; 12(9):4977-4997. PubMed ID: 33042401
[No Abstract] [Full Text] [Related]
4. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y
Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
[TBL] [Abstract][Full Text] [Related]
5. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.
Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q
Front Immunol; 2023; 14():1290839. PubMed ID: 38235126
[TBL] [Abstract][Full Text] [Related]
6. CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Chen K; Li L; Mao W; Shen D; Yao N; Zhang L
Ann Transl Med; 2021 Sep; 9(18):1443. PubMed ID: 34733995
[TBL] [Abstract][Full Text] [Related]
7. TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma.
Gao W; Zhang ZW; Wang HY; Li XD; Peng WT; Guan HY; Liao YX; Liu A
Front Genet; 2022; 13():895281. PubMed ID: 35754792
[No Abstract] [Full Text] [Related]
8. Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma.
Tan M; Lin X; Chen H; Ye W; Yi J; Li C; Liu J; Su J
PeerJ; 2023; 11():e15203. PubMed ID: 37090107
[TBL] [Abstract][Full Text] [Related]
9. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
Wang L; Jia Y; Jiang Z; Gao W; Wang B
Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma.
Liu Z; Chen S; Jia W; Qian Y; Yang X; Zhang M; Fang T; Liu H
Front Oncol; 2023; 13():1113781. PubMed ID: 37064086
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Aldehyde Dehydrogenase 2 as a Prognostic Marker Associated with Immune Cell infiltration and Chemotherapy Efficacy in Head and Neck Squamous Cell Carcinoma.
Lin YH; Yang YF; Liao JB; Chang TS; Janesha UGS; Shiue YL
J Cancer; 2023; 14(10):1689-1706. PubMed ID: 37476181
[No Abstract] [Full Text] [Related]
13. Identification of NUTF2 as a Candidate Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
Zhang R; Gao Y
Onco Targets Ther; 2021; 14():5455-5467. PubMed ID: 35221694
[TBL] [Abstract][Full Text] [Related]
14. Screening of four signature genes for clinical testing through bioinformatics and in vitro methods in head and neck squamous cell carcinoma.
Javed M; Bukhari RS; Rasool R; Alhomrani M; Alghamdi SA; Habeeballah H; Ramzan F; Baothman BK; Kashif M; Almaghrabi S; Izmirly AM; Khalid SY
Am J Cancer Res; 2023; 13(5):1826-1844. PubMed ID: 37293145
[TBL] [Abstract][Full Text] [Related]
15. Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma.
Li Y; Liu H
Cancer Biomark; 2022; 34(3):359-374. PubMed ID: 35068446
[TBL] [Abstract][Full Text] [Related]
16. Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma.
Cui K; Yao X; Wei Z; Yang Y; Liu X; Huang Z; Huo H; Tang J; Xie Y
Front Genet; 2022; 13():917344. PubMed ID: 36186458
[No Abstract] [Full Text] [Related]
17. Systematic analysis of expression and prognostic significance for MCM family in head and neck squamous cell carcinoma.
Sun E; Peng L; Liu Z; Yan Z; Chen M; Zheng J
Histol Histopathol; 2024 Apr; 39(4):471-482. PubMed ID: 37526267
[TBL] [Abstract][Full Text] [Related]
18. Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma.
Hu K; Yao L; Zhou L; Li J
Int J Gen Med; 2022; 15():2463-2474. PubMed ID: 35282653
[TBL] [Abstract][Full Text] [Related]
19. Exostoisns (EXT1/2) in Head and Neck Cancers: An In Silico Analysis and Clinical Correlates.
Wang Y; Huang Y; Zhu H; Guo Z; Cheng J; Zhang C; Zhong M
Int Dent J; 2024 Jun; 74(3):446-453. PubMed ID: 37989698
[TBL] [Abstract][Full Text] [Related]
20. Identifying the Therapeutic and Prognostic Role of the CD8+ T Cell-Related Gene ALDH2 in Head and Neck Squamous Cell Carcinoma.
Zhang H; Li Z; Zheng Y
Cancer Inform; 2022; 21():11769351221139252. PubMed ID: 36570380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
